Vaccine stocks fall sharply after Trump appoints Robert F Kennedy Jr as health secretary

Stocks of major vaccine manufacturers fell sharply after President-elect Donald Trump appointed Robert F. Kennedy Jr., a known vaccine skeptic, as head of the Department of Health and Human Services. Moderna, Pfizer, and Novavax experienced significant declines. Moderna's shares dropped 5.6% to $39.77, while Novavax fell 7% and Pfizer decreased 2.6% to $26.02. This decline continues a trend seen throughout 2023, with Moderna's stock down over 60% since January. Kennedy's appointment raises concerns about potential changes in public health policy and vaccine safety perceptions. His history of promoting anti-vaccine views may influence public support for vaccinations, according to health experts.